Results per Page:
Deciphering interactions between colorectal cancer risk factors
From the GECCO Coordinating Center, Public Health Sciences Division
Aspirin and its cousins linked to longer survival after colorectal cancer
Large study of preventive drugs for colorectal cancer survivors finds link to decreased mortality — but only for those with certain tumor genetics
Fred Hutch study suggests NSAIDs improve survival for certain colorectal cancer patients
Findings published in Journal of Clinical Oncology show NSAID benefits associated with cancer subtype and timing of drug’s use
Aspirin significantly reduces esophageal-cancer risk in people with most-aggressive form of Barrett's esophagus
Study also identifies biomarkers that predict which patients are most likely to get cancer